Anti-E alloimmunisation is a less common cause of haemolytic disease in the newborn (HDN) and is usually associated with mild to moderate clinical manifestations, that are often less severe than anti-D immunisation. Conventional treatments for HDN are phototherapy and exchange transfusion, the latter still representing a high-risk procedure. Currently, intravenous immunoglobulin has been used as alternative treatment for HDN to reduce the need for exchange transfusion, as well as the length of phototherapy and hospitalisation. We report a case of anti-E HDN treated successfully with intravenous immunoglobulin, as adjuvant treatment to phototherapy.
|Numero di pagine||3|
|Rivista||THE JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE|
|Stato di pubblicazione||Pubblicato - 2010|
- anti-E hemolytic disease in the newborn.